adenosine monophosphate has been researched along with thienopyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humphries, RG; van Giezen, JJ | 1 |
| Jilma, B; Krumphuber, J; Siller-Matula, JM | 1 |
| Caglayan, E; Er, F; Erdmann, E; Gassanov, N | 1 |
| Angiolillo, DJ; Brtko, M; Cannon, LA; Chandna, H; Chronos, N; Dietrich, M; Dyke, CM; Firstenberg, MS; Holmes, DR; Hutyra, M; Liu, T; Manoukian, SV; Montalescot, G; Prats, J; Price, M; Ramaiahm, C; Todd, M; Topo, EJ; Tummala, P; Voeltz, M; Welsby, I | 1 |
3 review(s) available for adenosine monophosphate and thienopyridine
| Article | Year |
|---|---|
Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Administration, Oral; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Rabbits; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor | 2005 |
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.
Topics: Adenosine; Adenosine Monophosphate; Benzofurans; Blood Platelets; Carbamates; Clinical Trials as Topic; Clopidogrel; Humans; Lactones; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Receptor, PAR-1; Receptors, Proteinase-Activated; Thiophenes; Ticagrelor; Ticlopidine; von Willebrand Factor | 2010 |
[ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease].
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Pyridines; Receptors, Purinergic P2; Stents; Ticlopidine | 2011 |
1 trial(s) available for adenosine monophosphate and thienopyridine
| Article | Year |
|---|---|
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
Topics: Adenosine Monophosphate; Administration, Oral; Adult; Aged; Aged, 80 and over; Blood Transfusion; Coronary Artery Bypass; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Injections, Intravenous; Male; Middle Aged; Placebo Effect; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Premedication; Prevalence; Purinergic P2Y Receptor Antagonists; Pyridines; Risk Assessment; Treatment Outcome; United States | 2013 |